<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31582731</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-4889</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Cell death &amp; disease</Title><ISOAbbreviation>Cell Death Dis</ISOAbbreviation></Journal><ArticleTitle>C9-ALS/FTD-linked proline-arginine dipeptide repeat protein associates with paraspeckle components and increases paraspeckle formation.</ArticleTitle><Pagination><StartPage>746</StartPage><MedlinePgn>746</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">746</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41419-019-1983-5</ELocationID><Abstract><AbstractText>A GGGGCC hexanucleotide repeat expansion in the C9ORF72 gene has been identified as the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. The repeat expansion undergoes unconventional translation to produce five dipeptide repeat proteins (DPRs). Although DPRs are thought to be neurotoxic, the molecular mechanism underlying the DPR-caused neurotoxicity has not been fully elucidated. The current study shows that poly-proline-arginine (poly-PR), the most toxic DPR in vitro, binds to and up-regulates nuclear paraspeckle assembly transcript 1 (NEAT1) that plays an essential role as a scaffold non-coding RNA during the paraspeckle formation. The CRISPR-assisted up-regulation of endogenous NEAT1 causes neurotoxicity. We also show that the poly-PR modulates the function of several paraspeckle-localizing heterogeneous nuclear ribonucleoproteins. Furthermore, dysregulated expression of TAR DNA-binding protein 43 (TDP-43) up-regulates NEAT1 expression and induces neurotoxicity. These results suggest that the increase in the paraspeckle formation may be involved in the poly-PR- and TDP-43-mediated neurotoxicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Medicine, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shibagaki</LastName><ForeName>Yoshio</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Biochemistry, School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hattori</LastName><ForeName>Seisuke</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Biochemistry, School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuoka</LastName><ForeName>Masaaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Medicine, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan. sakimatu@tokyo-med.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Death Dis</MedlineTA><NlmUniqueID>101524092</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034441">Heterogeneous-Nuclear Ribonucleoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C577276">NEAT1 long non-coding RNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009498">Neurotoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034441" MajorTopicYN="N">Heterogeneous-Nuclear Ribonucleoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009498" MajorTopicYN="N">Neurotoxins</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062085" MajorTopicYN="N">RNA, Long Noncoding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31582731</ArticleId><ArticleId IdType="pmc">PMC6776546</ArticleId><ArticleId IdType="doi">10.1038/s41419-019-1983-5</ArticleId><ArticleId IdType="pii">10.1038/s41419-019-1983-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr., Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Rademakers R, Neumann M, Mackenzie IR. Advances in understanding the molecular basis of frontotemporal dementia. Nat. Rev. Neurol. 2012;8:423&#x2013;434. doi: 10.1038/nrneurol.2012.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2012.117</ArticleId><ArticleId IdType="pmc">PMC3629543</ArticleId><ArticleId IdType="pubmed">22732773</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C, Ravenscroft TA, Sanchez-Contreras M, Rademakers R. Genetics of FTLD: overview and what else we can expect from genetic studies. J. Neurochem. 2016;138:32&#x2013;53. doi: 10.1111/jnc.13622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13622</ArticleId><ArticleId IdType="pubmed">27009575</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao FB, Almeida S, Lopez-Gonzalez R. Dysregulated molecular pathways in amyotrophic lateral sclerosis-frontotemporal dementia spectrum disorder. EMBO J. 2017;36:2931&#x2013;2950. doi: 10.15252/embj.201797568.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797568</ArticleId><ArticleId IdType="pmc">PMC5641681</ArticleId><ArticleId IdType="pubmed">28916614</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleary JD, Pattamatta A, Ranum LPW. Repeat-associated non-ATG (RAN) translation. J. Biol. Chem. 2018;293:16127&#x2013;16141. doi: 10.1074/jbc.R118.003237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R118.003237</ArticleId><ArticleId IdType="pmc">PMC6200949</ArticleId><ArticleId IdType="pubmed">30213863</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Taylor JP. The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front. Mol. Neurosci. 2017;10:35. doi: 10.3389/fnmol.2017.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Shibagaki Y, Hattori S, Matsuoka M. The proline-arginine repeat protein linked to C9-ALS/FTD causes neuronal toxicity by inhibiting the DEAD-box RNA helicase-mediated ribosome biogenesis. Cell Death Dis. 2018;9:975. doi: 10.1038/s41419-018-1028-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1028-5</ArticleId><ArticleId IdType="pmc">PMC6155127</ArticleId><ArticleId IdType="pubmed">30250194</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki YT, Ideue T, Sano M, Mituyama T, Hirose T. MENepsilon/beta noncoding RNAs are essential for structural integrity of nuclear paraspeckles. Proc. Natl Acad. Sci. USA. 2009;106:2525&#x2013;2530. doi: 10.1073/pnas.0807899106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807899106</ArticleId><ArticleId IdType="pmc">PMC2650297</ArticleId><ArticleId IdType="pubmed">19188602</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunwoo H, et al. MEN epsilon/beta nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res. 2009;19:347&#x2013;359. doi: 10.1101/gr.087775.108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.087775.108</ArticleId><ArticleId IdType="pmc">PMC2661813</ArticleId><ArticleId IdType="pubmed">19106332</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki T, et al. Functional domains of NEAT1 architectural lncRNA induce paraspeckle assembly through phase separation. Mol. Cell. 2018;70:1038&#x2013;1053.e1037. doi: 10.1016/j.molcel.2018.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.05.019</ArticleId><ArticleId IdType="pubmed">29932899</ArticleId></ArticleIdList></Reference><Reference><Citation>Naganuma T, et al. Alternative 3&#x2019;-end processing of long noncoding RNA initiates construction of nuclear paraspeckles. EMBO J. 2012;31:4020&#x2013;4034. doi: 10.1038/emboj.2012.251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2012.251</ArticleId><ArticleId IdType="pmc">PMC3474925</ArticleId><ArticleId IdType="pubmed">22960638</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong KW, et al. Whole-genome screening identifies proteins localized to distinct nuclear bodies. J. Cell Biol. 2013;203:149&#x2013;164. doi: 10.1083/jcb.201303145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201303145</ArticleId><ArticleId IdType="pmc">PMC3798253</ArticleId><ArticleId IdType="pubmed">24127217</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki T, Hirose T. The building process of the functional paraspeckle with long non-coding RNAs. Front Biosci. 2015;7:1&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">25553361</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa, S., Yamazaki, T. &amp; Hirose, T. Molecular dissection of nuclear paraspeckles: towards understanding the emerging world of the RNP milieu. Open Biol. 8, 180150 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6223218</ArticleId><ArticleId IdType="pubmed">30355755</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasanth KV, et al. Regulating gene expression through RNA nuclear retention. Cell. 2005;123:249&#x2013;263. doi: 10.1016/j.cell.2005.08.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.08.033</ArticleId><ArticleId IdType="pubmed">16239143</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LL, Carmichael GG. Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. Mol. Cell. 2009;35:467&#x2013;478. doi: 10.1016/j.molcel.2009.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2009.06.027</ArticleId><ArticleId IdType="pmc">PMC2749223</ArticleId><ArticleId IdType="pubmed">19716791</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirose T, et al. NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodies. Mol. Biol. Cell. 2014;25:169&#x2013;183. doi: 10.1091/mbc.e13-09-0558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e13-09-0558</ArticleId><ArticleId IdType="pmc">PMC3873887</ArticleId><ArticleId IdType="pubmed">24173718</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura K, et al. Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Mol. Cell. 2014;53:393&#x2013;406. doi: 10.1016/j.molcel.2014.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.01.009</ArticleId><ArticleId IdType="pubmed">24507715</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottini S, et al. Post-transcriptional gene silencing mediated by microRNAs is controlled by nucleoplasmic Sfpq. Nat. Commun. 2017;8:1189. doi: 10.1038/s41467-017-01126-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01126-x</ArticleId><ArticleId IdType="pmc">PMC5662751</ArticleId><ArticleId IdType="pubmed">29084942</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, et al. NEAT1 scaffolds RNA-binding proteins and the Microprocessor to globally enhance pri-miRNA processing. Nat. Struct. Mol. Biol. 2017;24:816&#x2013;824. doi: 10.1038/nsmb.3455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3455</ArticleId><ArticleId IdType="pmc">PMC5766049</ArticleId><ArticleId IdType="pubmed">28846091</ArticleId></ArticleIdList></Reference><Reference><Citation>An H, Williams NG, Shelkovnikova TA. NEAT1 and paraspeckles in neurodegenerative diseases: a missing lnc found? Noncoding RNA Res. 2018;3:243&#x2013;252. doi: 10.1016/j.ncrna.2018.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2018.11.003</ArticleId><ArticleId IdType="pmc">PMC6257911</ArticleId><ArticleId IdType="pubmed">30533572</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto Y, et al. The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol. Brain. 2013;6:31. doi: 10.1186/1756-6606-6-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-31</ArticleId><ArticleId IdType="pmc">PMC3729541</ArticleId><ArticleId IdType="pubmed">23835137</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova TA, et al. Protective paraspeckle hyper-assembly downstream of TDP-43 loss of function in amyotrophic lateral sclerosis. Mol. Neurodegener. 2018;13:30. doi: 10.1186/s13024-018-0263-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0263-7</ArticleId><ArticleId IdType="pmc">PMC5984788</ArticleId><ArticleId IdType="pubmed">29859124</ArticleId></ArticleIdList></Reference><Reference><Citation>An H, et al. ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles. Acta Neuropathol. Commun. 2019;7:7. doi: 10.1186/s40478-019-0658-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0658-x</ArticleId><ArticleId IdType="pmc">PMC6330737</ArticleId><ArticleId IdType="pubmed">30642400</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuiji H, et al. Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Mol. Med. 2013;5:221&#x2013;234. doi: 10.1002/emmm.201202303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201202303</ArticleId><ArticleId IdType="pmc">PMC3569639</ArticleId><ArticleId IdType="pubmed">23255347</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennig S, et al. Prion-like domains in RNA binding proteins are essential for building subnuclear paraspeckles. J. Cell. Biol. 2015;210:529&#x2013;539. doi: 10.1083/jcb.201504117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504117</ArticleId><ArticleId IdType="pmc">PMC4539981</ArticleId><ArticleId IdType="pubmed">26283796</ArticleId></ArticleIdList></Reference><Reference><Citation>Salton M, et al. Matrin 3 binds and stabilizes mRNA. PLoS ONE. 2011;6:e23882. doi: 10.1371/journal.pone.0023882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023882</ArticleId><ArticleId IdType="pmc">PMC3157474</ArticleId><ArticleId IdType="pubmed">21858232</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng AW, et al. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res. 2013;23:1163&#x2013;1171. doi: 10.1038/cr.2013.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2013.122</ArticleId><ArticleId IdType="pmc">PMC3790238</ArticleId><ArticleId IdType="pubmed">23979020</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulcsar PI, et al. Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage. Genome Biol. 2017;18:190. doi: 10.1186/s13059-017-1318-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-017-1318-8</ArticleId><ArticleId IdType="pmc">PMC6389135</ArticleId><ArticleId IdType="pubmed">28985763</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Lee K, Matsuoka M. TDP-43-induced death is associated with altered regulation of BIM and Bcl-xL and attenuated by caspase-mediated TDP-43 cleavage. J. Biol. Chem. 2011;286:13171&#x2013;13183. doi: 10.1074/jbc.M110.197483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.197483</ArticleId><ArticleId IdType="pmc">PMC3075664</ArticleId><ArticleId IdType="pubmed">21339291</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Shibagaki Y, Hattori S, Matsuoka M. Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs. Hum. Mol. Genet. 2015;24:1513&#x2013;1527. doi: 10.1093/hmg/ddu563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu563</ArticleId><ArticleId IdType="pubmed">25378556</ArticleId></ArticleIdList></Reference><Reference><Citation>Eksioglu YZ, et al. Human neuroblastoma growth inhibitory factor (h-NGIF), derived from human astrocytoma conditioned medium, has neurotrophic properties. Brain Res. 1994;644:282&#x2013;290. doi: 10.1016/0006-8993(94)91691-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(94)91691-8</ArticleId><ArticleId IdType="pubmed">8050039</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudo H, et al. Antibody-regulated neurotoxic function of cell-surface beta-amyloid precursor protein. Mol. Cell. Neurosci. 2000;16:708&#x2013;723. doi: 10.1006/mcne.2000.0910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mcne.2000.0910</ArticleId><ArticleId IdType="pubmed">11124892</ArticleId></ArticleIdList></Reference><Reference><Citation>Banker GA, Cowan WM. Rat hippocampal neurons in dispersed cell culture. Brain Res. 1977;126:397&#x2013;342. doi: 10.1016/0006-8993(77)90594-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(77)90594-7</ArticleId><ArticleId IdType="pubmed">861729</ArticleId></ArticleIdList></Reference><Reference><Citation>Marko M, Leichter M, Patrinou-Georgoula M, Guialis A. hnRNP M interacts with PSF and p54(nrb) and co-localizes within defined nuclear structures. Exp. Cell Res. 2010;316:390&#x2013;400. doi: 10.1016/j.yexcr.2009.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2009.10.021</ArticleId><ArticleId IdType="pubmed">19874820</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K, et al. Characterization of membrane penetration and cytotoxicity of C9orf72-encoding arginine-rich dipeptides. Sci. Rep. 2018;8:12740. doi: 10.1038/s41598-018-31096-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31096-z</ArticleId><ArticleId IdType="pmc">PMC6109075</ArticleId><ArticleId IdType="pubmed">30143685</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C, et al. The long noncoding RNA NEAT1 is elevated in polyglutamine repeat expansion diseases and protects from disease-gene dependent toxicities. Hum. Mol. Genet. 2018;27:4303&#x2013;4314. doi: 10.1093/hmg/ddy193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy193</ArticleId><ArticleId IdType="pmc">PMC6276831</ArticleId><ArticleId IdType="pubmed">30239724</ArticleId></ArticleIdList></Reference><Reference><Citation>Konermann S, et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. 2015;517:583&#x2013;588. doi: 10.1038/nature14136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14136</ArticleId><ArticleId IdType="pmc">PMC4420636</ArticleId><ArticleId IdType="pubmed">25494202</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A, Vest KE, Pavlath GK, Corbett AH. Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing. Nucleic Acids Res. 2017;45:10706&#x2013;10725. doi: 10.1093/nar/gkx786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx786</ArticleId><ArticleId IdType="pmc">PMC5737383</ArticleId><ArticleId IdType="pubmed">28977530</ArticleId></ArticleIdList></Reference><Reference><Citation>Geuens T, Bouhy D, Timmerman V. The hnRNP family: insights into their role in health and disease. Hum. Genet. 2016;135:851&#x2013;867. doi: 10.1007/s00439-016-1683-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-016-1683-5</ArticleId><ArticleId IdType="pmc">PMC4947485</ArticleId><ArticleId IdType="pubmed">27215579</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauger DM, Lin C, Garcia-Blanco M. A. hnRNP H and hnRNP F complex with Fox2 to silence fibroblast growth factor receptor 2 exon IIIc. Mol. Cell. Biol. 2008;28:5403&#x2013;5419. doi: 10.1128/MCB.00739-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00739-08</ArticleId><ArticleId IdType="pmc">PMC2519734</ArticleId><ArticleId IdType="pubmed">18573884</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou MY, Rooke N, Turck CW, Black DL. hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Mol. Cell. Biol. 1999;19:69&#x2013;77. doi: 10.1128/MCB.19.1.69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.19.1.69</ArticleId><ArticleId IdType="pmc">PMC83866</ArticleId><ArticleId IdType="pubmed">9858532</ArticleId></ArticleIdList></Reference><Reference><Citation>Caputi M, Zahler AM. Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H&#x2019;/F/2H9 family. J. Biol. Chem. 2001;276:43850&#x2013;43859. doi: 10.1074/jbc.M102861200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M102861200</ArticleId><ArticleId IdType="pubmed">11571276</ArticleId></ArticleIdList></Reference><Reference><Citation>Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 2003;72:291&#x2013;336. doi: 10.1146/annurev.biochem.72.121801.161720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.72.121801.161720</ArticleId><ArticleId IdType="pubmed">12626338</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Contreras R, et al. Intronic binding sites for hnRNP A/B and hnRNP F/H proteins stimulate pre-mRNA splicing. PLoS Biol. 2006;4:e21. doi: 10.1371/journal.pbio.0040021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0040021</ArticleId><ArticleId IdType="pmc">PMC1326234</ArticleId><ArticleId IdType="pubmed">16396608</ArticleId></ArticleIdList></Reference><Reference><Citation>Du J, Wang Q, Ziegler SF, Zhou B. FOXP3 interacts with hnRNPF to modulate pre-mRNA alternative splicing. J. Biol. Chem. 2018;293:10235&#x2013;10244. doi: 10.1074/jbc.RA117.001349.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA117.001349</ArticleId><ArticleId IdType="pmc">PMC6028976</ArticleId><ArticleId IdType="pubmed">29773655</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki T, et al. TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency. Genes Dev. 2018;32:1161&#x2013;1174. doi: 10.1101/gad.316984.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.316984.118</ArticleId><ArticleId IdType="pmc">PMC6120717</ArticleId><ArticleId IdType="pubmed">30115631</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, et al. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167:774&#x2013;788.e717. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 2011;14:452&#x2013;458. doi: 10.1038/nn.2778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P, et al. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch. Neurol. 2008;65:1481&#x2013;1487. doi: 10.1001/archneur.65.11.1481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.65.11.1481</ArticleId><ArticleId IdType="pmc">PMC2690860</ArticleId><ArticleId IdType="pubmed">19001167</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J. Exp. Med. 2011;208:2429&#x2013;2447. doi: 10.1084/jem.20111313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111313</ArticleId><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E, et al. TDP-43 plasma levels are higher in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2012;13:446&#x2013;451. doi: 10.3109/17482968.2012.703208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.703208</ArticleId><ArticleId IdType="pubmed">22873561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai T, et al. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2009;117:55&#x2013;62. doi: 10.1007/s00401-008-0456-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0456-1</ArticleId><ArticleId IdType="pubmed">18989684</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M, et al. Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis. Acta Neurol. Scand. 2010;122:367&#x2013;372. doi: 10.1111/j.1600-0447.2010.01553.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.2010.01553.x</ArticleId><ArticleId IdType="pubmed">20175762</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa S, Naganuma T, Shioi G, Hirose T. Paraspeckles are subpopulation-specific nuclear bodies that are not essential in mice. J. Cell. Biol. 2011;193:31&#x2013;39. doi: 10.1083/jcb.201011110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201011110</ArticleId><ArticleId IdType="pmc">PMC3082198</ArticleId><ArticleId IdType="pubmed">21444682</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Harvey AR, Hodgetts SI, Fox AH. Functional dissection of NEAT1 using genome editing reveals substantial localization of the NEAT1_1 isoform outside paraspeckles. RNA. 2017;23:872&#x2013;881. doi: 10.1261/rna.059477.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.059477.116</ArticleId><ArticleId IdType="pmc">PMC5435860</ArticleId><ArticleId IdType="pubmed">28325845</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunwoo JS, et al. Altered expression of the long noncoding RNA NEAT1 in Huntington&#x2019;s disease. Mol. Neurobiol. 2017;54:1577&#x2013;1586. doi: 10.1007/s12035-016-9928-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-9928-9</ArticleId><ArticleId IdType="pubmed">27221610</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan W, Chen ZY, Chen JQ, Chen HM. LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson&#x2019;s disease through stabilizing PINK1 protein. Biochem. Biophys. Res. Commun. 2018;496:1019&#x2013;1024. doi: 10.1016/j.bbrc.2017.12.149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.12.149</ArticleId><ArticleId IdType="pubmed">29287722</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Lu Z. Long non-coding RNA NEAT1 mediates the toxic of Parkinson&#x2019;s disease induced by MPTP/MPP+ via regulation of gene expression. Clin. Exp. Pharmacol. Physiol. 2018;45:841&#x2013;848. doi: 10.1111/1440-1681.12932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1440-1681.12932</ArticleId><ArticleId IdType="pubmed">29575151</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Protter DS, Rosen MK, Parker R. Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. Mol. Cell. 2015;60:208&#x2013;219. doi: 10.1016/j.molcel.2015.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.08.018</ArticleId><ArticleId IdType="pmc">PMC4609299</ArticleId><ArticleId IdType="pubmed">26412307</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin, Y. &amp; Brangwynne, C. P. Liquid phase condensation in cell physiology and disease. Science357, eaaf4382 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28935776</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, et al. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T, et al. ALS/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron. 2015;88:678&#x2013;690. doi: 10.1016/j.neuron.2015.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.030</ArticleId><ArticleId IdType="pmc">PMC4660210</ArticleId><ArticleId IdType="pubmed">26526393</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Yokoshi M, Okada H, Kawahara Y. The cleavage pattern of TDP-43 determines its rate of clearance and cytotoxicity. Nat. Commun. 2015;6:6183. doi: 10.1038/ncomms7183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7183</ArticleId><ArticleId IdType="pubmed">25630387</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>